11,389 Shares in CME Group Inc. $CME Bought by Elevation Point Wealth Partners LLC

Elevation Point Wealth Partners LLC purchased a new position in CME Group Inc. (NASDAQ:CME) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 11,389 shares of the financial services provider’s stock, valued at approximately $2,515,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. BlackRock Inc. purchased a new stake in CME Group during the 2nd quarter valued at about $6,749,965,000. Norges Bank purchased a new position in CME Group in the 4th quarter worth approximately $1,523,241,000. Bank of New York Mellon Corp bought a new stake in CME Group in the second quarter valued at approximately $867,313,000. Alphabet Inc. bought a new stake in CME Group in the second quarter valued at approximately $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of CME Group during the second quarter valued at approximately $629,771,000. 87.75% of the stock is owned by institutional investors.

CME Group Stock Performance

Shares of CME opened at $274.98 on Monday. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm’s 50-day moving average price is $251.17 and its 200-day moving average price is $279.57. The firm has a market capitalization of $98.88 billion, a price-to-earnings ratio of 23.32, a PEG ratio of 3.27 and a beta of 0.23.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the business posted $2.96 earnings per share. CME Group’s quarterly revenue was up .8% compared to the same quarter last year. Sell-side analysts anticipate that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be given a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. CME Group’s payout ratio is currently 44.11%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on CME shares. Weiss Ratings downgraded shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Raymond James Financial reissued an “outperform” rating and issued a $320.00 price target on shares of CME Group in a report on Thursday, July 2nd. Barclays decreased their price objective on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 9th. Wall Street Zen downgraded shares of CME Group from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 1st. Finally, The Goldman Sachs Group dropped their target price on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a report on Tuesday, June 30th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus price target of $288.56.

Insiders Place Their Bets

In other news, Director William R. Shepard acquired 325 shares of the firm’s stock in a transaction on Thursday, June 25th. The stock was acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.